Information Provided By:
Fly News Breaks for April 7, 2015
ACUR, EGLT
Apr 7, 2015 | 08:20 EDT
After Egalet revealed that Purdue has filed a lawsuit against the company and Acura Pharmaceuticals (ACUR) alleging that Egalet's OXAYDO infringes one of its patents, JMP Securities remains confident in Egalet’s freedom to operate with the product and in its ability to protect its market exclusivity.. The firm believes that Egalet's term of exclusivity for the drug is unlikely to be shortened as a result of the lawsuit. It reiterates a $24 price target and Outperform rating on Egalet.
News For EGLT;ACUR From the Last 2 Days
There are no results for your query EGLT;ACUR